http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.
변환된 중국어를 복사하여 사용하시면 됩니다.
불량한 임신 결과 예측을 위한 임신중기 산모 혈청 inhibin-A 측정의 연관성
오현명 ( Hyon Myong Oh ),김석영 ( Suk Young Kim ),이순표 ( Soon Pyo Lee ),손유경 ( You Kyoung Sohn ),이경훈 ( Gyoung Hoon Lee ),김정민 ( Jeong Min Kim ) 대한산부인과학회 2008 Obstetrics & Gynecology Science Vol.51 No.11
Objectives: To investigate the association between abnormal inhibin-A level in Quad test during the 15 and 18 weeks of gestation and adverse pregnancy outcomes. Methods: From January 2005 to March 2007, women who delivered their babies at our institute after Quad test in second trimester of gestation (N=140) were enrolled. We measured inhibin-A levels (MoM) and other serum markers of the Quad test. And we analyzed the incidence of adverse pregnancy outcomes such as preterm birth, fetal growth restriction, pregnancy induced hypertension, fetal loss, and intrauterine fetal death. Results: When the pregnancy outcomes are hypertensive disorders and fetal losses, the inhibin-A levels are is more elevated with statistically significance. Inhibin-A and hCG levels are elevated with significantly at hypertensive disorders and fetal losses. But inhibin-A levels are more significantly associated with abnormal pregnancy outcomes than hCG. Conclusions: Measurement of inhibin-A levels may be the most useful among other serum markers of the Quad test in predicting adverse obstetric outcomes.